
Daré Bioscience, Inc.
DARENASDAQHealthcareBiotechnology
As of Nov 10, 2026 close
- Market cap
- $10.31M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.61$3.78
- Volume (live)
- -
- Avg. volume (3M)
- 145.35K
Daré Bioscience (DARE) Stock Price & Financial Analysis
Daré Bioscience Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.68 - $0.71 |
|---|---|
| 52-Week High | $3.78 |
| 52-Week Low | $0.61 |
| Open | $0.70 |
| Volume (last close) | 160.75K |
| Average Volume (3M) | 145.35K |
| Revenue (TTM) | 1.37M |
|---|---|
| Net Income (TTM) | -10.99M |
| Free Cash Flow (TTM) | -11.76M |
| EPS (TTM) | −$0.78 |
| Profit Margin | -804.37% |
| Operating Margin | -813.38% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 10.31M |
|---|---|
| Shares Outstanding | 14.89M |
| Price to Sales (P/S) | 7.54 |
| Price to Book (P/B) | -18.40 |
| EV/EBITDA | 0.13 |
| 50-Day MA | $0.73 |
|---|---|
| 200-Day MA | $1.54 |
| 1-Year Change | −64.32% |
Source: Market prices and company fundamentals. Data as of Nov 10, 2026. Data sources and methodology
Daré Bioscience at a Glance
As of the Nov 10, 2026 close, Daré Bioscience (DARE) has a market capitalization of $10.31M. The stock trades at 7.5× sales. Over the trailing twelve months it lost $10.99M on revenue of $1.37M and burned $11.76M of free cash flow. Revenue grew 4366.5% year over year.
As of its latest reported balance sheet, it holds $12.62M in cash and securities against $1.77M of debt, a net cash position of $10.84M.
Daré Bioscience does not currently pay a dividend.
The share price is down 64.3% over the past year. At $0.69 (the Nov 10, 2026 close) it sits near the bottom of its 52-week range of $0.61 to $3.78, below its 200-day moving average of $1.54.
Based on 1 professional analyst rating from the past 90 days, the consensus is Hold.
Frequently Asked Questions About Daré Bioscience
What is the current stock price for DARE?
As of the Nov 10, 2026 close, DARE stock trades at $0.69. The 52-week range is $0.61–$3.78, with a day range of $0.68–$0.71.
What is the P/E ratio for DARE?
Daré Bioscience has no trailing P/E ratio because it reported a net loss over the last twelve months.
Does DARE pay dividends?
Daré Bioscience does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for DARE?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for DARE is Hold.
What is the market cap of DARE?
As of the Nov 10, 2026 close, Daré Bioscience's market capitalization is $10.3M, classifying it as a micro-cap company. Daré Bioscience operates in the Healthcare sector within the Biotechnology industry.